OTLKW
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
OTLKW
Delisted
OTLKW was delisted on the 16th of February, 2022.
6 hedge funds and large institutions have $256K invested in Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
$312K
Puts
–
Net Calls
+$312K
Net Calls Change
+$30K
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$41K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $130K | – | – | – |
|
|
SFM
2
Sphera Funds Management
Tel Aviv,
Israel
| $49K | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $41K | +$41K | +130,840 | New |
|
|
PC
4
PointState Capital
New York
| $32K | – | – | – |
|
|
CIA
5
Compass Ion Advisors
Conshohocken,
Pennsylvania
| $4K | – | – | – |
|